Qingdao Haier Biomedical Co., Ltd. (688139.SH) announced that on June 11, 2024, the company received a notice that its shareholder, Ningbo Meishan Bonded Port Area Qijun Private Equity Investment Partnership Enterprise (limited partnership) (referred to as "Qijun Investment"), had reduced its shareholding by more than 5% and its concerted action person by 1% or more, from February 2, 2023 to June 11, 2024, a cumulative reduction of 4.1077 million shares, or 1.29%.
Zhixin Finance APP news, Qingdao Haier Biomedical Co., Ltd. (688139.SH) announced that on June 11, 2024, the company received a notice that its shareholder, Ningbo Meishan Bonded Port Area Qijun Private Equity Investment Partnership Enterprise (limited partnership) (referred to as "Qijun Investment"), had reduced its shareholding by more than 5% and its concerted action person by 1% or more, from February 2, 2023 to June 11, 2024, a cumulative reduction of 4.1077 million shares, or 1.29%.